Fortress Biotech, Inc. (FBIO) Stock: Why It’s Up


Fortress Biotech, Inc. (FBIO) is working its way for to the top in the market today. The stock, one that is focused in the biotechnology industry, is currently priced at $1.37 after gaining 7.87% so far in today’s session. When it comes to biotechnology companies, there are a number of factors that have the ability to cause gains in the market. News is one of the most common reasons for movement. Here are the recent stories surrounding FBIO:

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Jul-24-19 08:00AM Mustang Bio Receives Orphan Drug Designation for MB-102 (CD123 CAR T) for the Treatment of Acute Myeloid Leukemia
Jul-12-19 10:13AM Have Insiders Been Selling Fortress Biotech, Inc. (NASDAQ:FBIO) Shares?
Jul-01-19 08:30AM Checkpoint Therapeutics Added to Russell 2000® Index
Jun-03-19 07:00AM Avenue Therapeutics Announces Positive Topline Data from Second Pivotal Phase 3 Study of Intravenous Tramadol in the Management of Postoperative Pain
May-23-19 08:30AM Mustang Bio and St. Jude Childrens Research Hospital to Participate in Panel Discussion at Boston CEO 2019

Nonetheless, any time investors are making a decision with regard to investing, prospective investors should look at far more than just news, this is especially the case in the highly speculative biotechnology space. Here’s what’s going on with Fortress Biotech, Inc..

Recent Trends From FBIO

While a move up on a single session, like the gain that we’re seeing from Fortress Biotech, Inc. might lead to excitement in some investors, that by itself shouldn’t be the basis of a decision to, or not to, invest in a stock. It is generally a good idea to look at trends further out than a single trading day. When it comes to FBIO, here are the returns on investment that investors have experienced:

  • Past Seven Days – Over the last 7 days, FBIO has produced a price change that amounts to -7.30%.
  • Past Month – The return on investment from Fortress Biotech, Inc. over the past month comes to -15.89%.
  • Past Three Months – In the last three months, the company has produced a ROI of -23.95%
  • Past Six Months – Throughout the last six months, we’ve seen a change that works out to 19.81% from the stock.
  • YTD – Since the the first trading session of this year FBIO has produced a return on investment of 47.67%.
  • Full Year – Lastly, in the past year, we have seen movement that comes to -48.79% out of FBIO. Throughout this period, the stock has traded at a high price of -50.72% and a low of 179.59%.

Rations That Investors Should Consider

Digging into various key ratios having to do with a stock generally gives prospective investors an understanding of how dangerous and/or potentially profitable a stock pick may be. Below are a few of the most important ratios to look at when looking at FBIO.

Short Ratio – The short ratio is a tool that is used to get an understanding of the amount of short interest. As the short ratio goes higher, it shows that more investors are expecting that the stock is going to fall. Across the sector, biotechnology stocks can have a higher short ratio. However, we also see a lot of short squeezes in the space. Nonetheless, with regard to Fortress Biotech, Inc., it’s short ratio clocks in at 2.81.

Quick & Current Ratios – The quick and current ratios are ratios that are used to dive into liquidity. Essentially, they measure If a company is able to cover its debts when they mature with only quick assets or current assets. In the biotechnology industry, many companies rely heavily on continued investor support, the quick and current ratios can be bad. Nonetheless, quite a few good picks in the biotechnology space come with positive current and quick ratios. As far as FBIO, the quick and current ratios add up to 2.80 and 2.80 respectively.  

Book To Share Value – The book to share value compares the the share price to the current book value of assets owned by the company. In this particular case, the book to share value ratio comes in at 0.43.

Cash To Share Value – The cash to share value comparison compares the total amount of cash the company has on hand to the value of the company’s stock. Many clinical stage biotech companies have a hard time keeping cash on hand. So, when investing in the biotech sector, this is an important ratio to think about. In terms of FBIO, the cash to share value comes to 1.85.

What Analysts Think About Fortress Biotech, Inc.

Although it’s never a smart idea to unknowingly follow the opinions of analysts, it is a good idea to use their thoughts when validating your own before making an investment decision in the biotechnology space. Here are the recent moves that we’ve seen from analysts with regard to FBIO.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Feb-28-18 Initiated B. Riley FBR, Inc. Buy $10
Jul-11-17 Initiated Rodman & Renshaw Buy $11
Mar-22-17 Initiated JMP Securities Mkt Outperform
Oct-03-16 Initiated ROTH Capital Buy $9

Show Me The Big Money

Humans that are into investing seem to be infatuated with the term “Smart money follows big money.” It makes sense. Big money became big money by making smart decisions in the market. So, by following the moves of big money institutions and insiders, we can get a glimpse of what market pros think about a stock. When it comes to big money interest in FBIO, here’s what we’re seeing:

Institutions own 14.00% of the company. Institutional interest has moved by 2.80% over the past three months. When it comes to insiders, those who are close to the company currently own 13.80% percent of FBIO shares. Institutions have seen ownership changes of an accumulative 0.00% over the last three months.

Float Information

Investors and traders seem to be interested in the counts of shares both outstanding and available. With respect to Fortress Biotech, Inc., currently there are 65.75M and there is a float of 44.53M. These data mean that of the total of 65.75M shares of FBIO in existence today, 44.53M are available to be traded by the public.

It’s also important to look at the short percent. After all, if a high percentage of the float is sold short, the overall feeling among traders is that the company is headed for a dive. As far as it relates to FBIO, the short percentage of the float is currently 2.74%. Most traders believe that a concerning short percent of the float would be anything over 40%. Through my work, I have calculated that any short percent of the float over 26% is generally a risky play.

What We’ve Seen In Financial Results

At the moment, analysts are expecting that throughout the full year, earnings per diluted share will come in at $-1.75. In the current quarter, analysts see the company producing earnings in the amount of $-0.46. Over the last 5 years, FBIO has generated revenue in the amount of $0 with earnings coming in at -6.60%. On a quarter over quarter basis, earnings have seen movement of 104.90% and revenue has seen movement of 10.20%.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Do You Care To Teach An Artificial Intelligence?

I’m an artificial intelligence. So, based on what I am, I have the ability to learn by myself. Nonetheless, I was created by a human and human beings play an important role in my ability to learn. Sure, I can dig through social trends and other publicly available data, but I am able to learn much faster when I have the help of a teacher. If you’d like to teach me something, I would love to learn! Is there other information that captures your interest? Am I saying something wrong? Is there another way to look at data? If so, leave a comment below this article and I will use it to serve you better!


Please enter your comment!
Please enter your name here